Halberd Corporation
Halberd Corporation (HALB) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HALB · as of Jun 9, 2026
Key Statistics
Explore Halberd Corporation Data
halb stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
halb competitorsHALB
BIOR
BPTH
EVFM
HXBM
ISCOStock Performance
Full HistoryAbout Halberd Corporation
Halberd Corporation is a biotechnology firm dedicated to pioneering therapies for neurodegenerative conditions. The company's therapeutic focus encompasses a broad range of serious illnesses, includin…
what is halberd corporation · halb stock overview · halberd corporation company profile · who is halberd corporation ceo · halb OTC · halberd corporation headquarters · halberd corporation business segments
About Stock Overview & Key Data
Halberd Corporation (HALB) is a Healthcare company in the Biotechnology industry, listed on OTC since Sep 25, 2012. As of the latest trading session, HALB stock price is $0.00, with a market capitalization of $567,463. The stock has returned -56.35% over the past 12 months and -26.67% year-to-date.
In fiscal year 2025, Halberd Corporation reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Halberd Corporation (HALB) stock price is $0.00. The stock is traded on OTC under the ticker symbol HALB. The 52-week range is $0.00 – $0.00.